There are at present 11 states which have legalized adult-use cannabis, and medical cannabis is authorized in 33 states, although the federal authorities lists marijuana as a Schedule I narcotic and doesn’t acknowledge it as having any medicinal properties.

Florida Representatives Matt Gaetz (FL-01) and Donna Shalala (FL-27) have launched bipartisan laws to facilitate cannabis analysis and research its potential medical advantages and public well being impacts.

On Thursday, September 12, Gaetz and Shalala launched the Increasing Hashish Analysis and Data Act (HB4322) which might create a nationwide cannabis analysis agenda and direct the U.S. Division of Well being and Human Providers to collect information on the well being impacts of cannabis.

“For years now, states throughout the nation have been liberalizing their cannabis legal guidelines with out making corresponding investments in growing a greater scientific understanding of the quick and long-term advantages and results of cannabis on human well being,” mentioned Consultant Shalala. “By rescheduling cannabis and directing our nationwide analysis infrastructure to check and accumulate information on the way it impacts well being outcomes, we’re not solely bringing federal cannabis coverage into the 21st century, however we’re additionally guaranteeing that we achieve this safely.”

HB4322 would set up a Nationwide Institutes of Well being Facilities of Excellence analysis designation and transfer cannabis to the Schedule III class from the Schedule I designation the place it has resided because the 1970s.

Florida Commissioner of Agriculture and Shopper Providers, Nikki Fried calls the Increasing Hashish Analysis and Data Act a welcome step ahead and says that federal cannabis coverage wants to alter to higher present secure and compassionate remedy choices for these in want.

Final week, the DEA proposed growing the quantity of cannabis produced for analysis to facilitate the rising quantity of accepted cannabis analysis in the US.